ABL Diagnostics Société anonyme (EPA: ABLD)
France
· Delayed Price · Currency is EUR 2.500
0.00 (0.00%)
Dec 20, 2024, 11:30 AM CET
EPA: ABLD Market Cap
ABLD has a market cap or net worth of €40.28 million as of December 20, 2024. Its market cap has decreased by -74.23% in one year.
Market Cap
40.28M
Enterprise Value
41.69M
Revenue
6.21M
Ranking
n/a
PE Ratio
218.16
Stock Price
€2.50
Market Cap Chart
Since November 17, 2000, ABLD's market cap has increased from 2.51M to 40.28M, an increase of 1,506.19%. That is a compound annual growth rate of 12.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 40.28M | -74.23% |
| Dec 29, 2023 | 156.30M | 3,819.50% |
| Dec 30, 2021 | 3.99M | 34.75% |
| Dec 31, 2020 | 2.96M | -59.03% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 114.43B |
| EssilorLuxottica Société anonyme | 105.61B |
| Sartorius Stedim Biotech S.A. | 18.02B |
| bioMérieux S.A. | 12.06B |
| Eurofins Scientific SE | 9.08B |
| Ipsen S.A. | 8.87B |
| Virbac SA | 2.59B |
| Ramsay Générale de Santé SA | 1.26B |